Global point of care (POC) diagnostics market is mainly segmented by product type, prescription, end users and by region/country. On the basis of product type, the market is segmented into glucose monitoring kit, hematology test kit, urinalysis test kit, coagulation monitoring kits, tumour/cancer markers test kit, cholesterol test kit, drugs of abuse testing kit, faecal occult test kit, infectious disease test kit, pregnancy and fertility test kit, cardiometabolic monitoring kit and others. The infectious disease test kit is further segmented into hepatitis test kit, HIV test kit, respiratory infections test kit, influenza test kit. Pregnancy and fertility test kits are further segmented into pregnancy test kit and fertility test kit, The various cardiometabolic monitoring kit includes cardiac markers kit, HbA1c test kit, electrolytes test kit and others. The global POC market is also segment by mode of prescription such as prescription POC test kit and Over-the-counter (OTC) kit. The major end users studied in the report are hospitals, homecare setting, research labs and others.
The report includes market size estimation for the regions such as Americas, Europe, Asia-Pacific and Middle East & Africa. Some of the world’s major IVD companies are operating in this market, which account for the major market share in the global Point Of Care Diagnostics market. The report includes market size estimation and forecast in terms of revenue (USD Million) from 2017 to 2023.
The companies which leads the global point of care diagnostics market are: Abaxis, Abbott Laboratories, Inc, Alere Inc. (acquired by Abbott Laboratories Inc.), Beckman Coulter, Inc. ( subsidiary of Danaher Corporation), Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher, Roche Diagnostics Limited (subsidiary of F. Hoffmann-La Roche Ltd.), Instrumentation Laboratory (A Werfen Company), Johnson & Johnson, Nova Biomedical, PTs Diagnostics, Siemens AG and Trinity Biotech.